BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 19058139)

  • 1. Oct4A is expressed by a subpopulation of prostate neuroendocrine cells.
    Sotomayor P; Godoy A; Smith GJ; Huss WJ
    Prostate; 2009 Mar; 69(4):401-10. PubMed ID: 19058139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific detection of OCT3/4 isoform A/B/B1 expression in solid (germ cell) tumours and cell lines: confirmation of OCT3/4 specificity for germ cell tumours.
    Rijlaarsdam MA; van Herk HA; Gillis AJ; Stoop H; Jenster G; Martens J; van Leenders GJ; Dinjens W; Hoogland AM; Timmermans M; Looijenga LH
    Br J Cancer; 2011 Sep; 105(6):854-63. PubMed ID: 21847120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of OCT4A and SPP1C transcript variant co-expression in early-stage lung adenocarcinoma.
    Koshimune S; Kosaka M; Mizuno N; Yamamoto H; Miyamoto T; Ebisui K; Toyooka S; Ohtsuka A
    BMC Cancer; 2020 Jun; 20(1):521. PubMed ID: 32503462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression analysis of putative stem cell markers in human benign and malignant prostate.
    Ugolkov AV; Eisengart LJ; Luan C; Yang XJ
    Prostate; 2011 Jan; 71(1):18-25. PubMed ID: 20583131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced overexpression of Oct4A in human dental pulp cells enhances pluripotency and multilineage differentiation capability.
    Liu L; Wu L; Wei X; Ling J
    Stem Cells Dev; 2015 Apr; 24(8):962-72. PubMed ID: 25422984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine Differentiation in Metastatic Conventional Prostate Cancer Is Significantly Increased in Lymph Node Metastases Compared to the Primary Tumors.
    Genitsch V; Zlobec I; Seiler R; Thalmann GN; Fleischmann A
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28788048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells.
    Le Magnen C; Bubendorf L; Ruiz C; Zlobec I; Bachmann A; Heberer M; Spagnoli GC; Wyler S; Mengus C
    Eur J Cancer; 2013 Mar; 49(4):955-63. PubMed ID: 23089465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression profile of undifferentiated cell transcription factor 1 in normal and cancerous human epithelia.
    Mouallif M; Albert A; Zeddou M; Ennaji MM; Delvenne P; Guenin S
    Int J Exp Pathol; 2014 Aug; 95(4):251-9. PubMed ID: 24738751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OCT4B modulates OCT4A expression as ceRNA in tumor cells.
    Li D; Yang ZK; Bu JY; Xu CY; Sun H; Tang JB; Lin P; Cheng W; Huang N; Cui RJ; Yu XG; Zheng XL
    Oncol Rep; 2015 May; 33(5):2622-30. PubMed ID: 25812694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and differential expression patterns of porcine OCT4 variants.
    Hwang JY; Oh JN; Lee DK; Choi KH; Park CH; Lee CK
    Reproduction; 2015 Jan; 149(1):55-66. PubMed ID: 25342174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [OCT4 expression in hepatocellular carcinoma and its clinical significance].
    Huang PZ; Lu CL; Li BK; Hong J; Huang L; Wang L; Zhang Y; Yuan YF
    Chin J Cancer; 2010 Jan; 29(1):111-16. PubMed ID: 20038322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Human Stem Cell Transcription Factors.
    Sneha S; Nagare RP; Manasa P; Vasudevan S; Shabna A; Ganesan TS
    Cell Reprogram; 2019 Aug; 21(4):171-180. PubMed ID: 31298562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostication of OCT4 isoform expression in prostate cancer.
    de Resende MF; Chinen LT; Vieira S; Jampietro J; da Fonseca FP; Vassallo J; Campos LC; GuimarĂ£es GC; Soares FA; Rocha RM
    Tumour Biol; 2013 Oct; 34(5):2665-73. PubMed ID: 23636800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced overexpression of OCT4A in human embryonic stem cells increases cloning efficiency.
    Tsai SC; Chang DF; Hong CM; Xia P; Senadheera D; Trump L; Mishra S; Lutzko C
    Am J Physiol Cell Physiol; 2014 Jun; 306(12):C1108-18. PubMed ID: 24627557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer.
    Samardzija C; Luwor RB; Volchek M; Quinn MA; Findlay JK; Ahmed N
    Mol Cancer; 2015 Aug; 14():152. PubMed ID: 26260289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer.
    Yasumizu Y; Rajabi H; Jin C; Hata T; Pitroda S; Long MD; Hagiwara M; Li W; Hu Q; Liu S; Yamashita N; Fushimi A; Kui L; Samur M; Yamamoto M; Zhang Y; Zhang N; Hong D; Maeda T; Kosaka T; Wong KK; Oya M; Kufe D
    Nat Commun; 2020 Jan; 11(1):338. PubMed ID: 31953400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of Oct4 variants and pseudogenes in normal urothelium and urothelial cancer.
    Wezel F; Pearson J; Kirkwood LA; Southgate J
    Am J Pathol; 2013 Oct; 183(4):1128-1136. PubMed ID: 23933063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. All the Tested Human Somatic Cells Express Both Oct4A and Its Pseudogenes but Express Oct4A at Much Lower Levels Compared with Its Pseudogenes and Human Embryonic Stem Cells.
    Xu G; Yang L; Zhang W; Wei X
    Stem Cells Dev; 2015 Jul; 24(13):1546-57. PubMed ID: 25687509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OCT4B2, a novel alternative spliced variant of OCT4, is significantly upregulated under heat-stress condition and downregulated in differentiated cells.
    Poursani EM; Mehravar M; Soltani BM; Mowla SJ
    Tumour Biol; 2017 Oct; 39(10):1010428317724280. PubMed ID: 29022482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of stem cell markers and ABCG2 in recurrent prostate cancer.
    Guzel E; Karatas OF; Duz MB; Solak M; Ittmann M; Ozen M
    Prostate; 2014 Nov; 74(15):1498-505. PubMed ID: 25175483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.